All lobbying filings
VENN STRATEGIES
Lobbying for UCB, INC. · Biopharmaceutical company dealing in severe diseases in immunology and neurology.
Filing
1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$40,000.00
What the client paid this registrant for the period.
Client based in
Georgia
Lobbyists on this filing
2
-
SAMUEL GOODSTEIN New on this filingPreviously held: Chief of Staff - Sen. Sheldon Whitehouse (D-RI)
-
JUSTIN ROBERT LIVESEY New on this filingPreviously held: Legislative Aide - Sen. Ron Johnson (R-WI)
Government bodies contacted
2
Lobbying activity
2
Policies related to biopharmaceutical access and innovation.
International tax, corporate tax rate, and research and development tax issues.